FCGRT Monoclonal Antibody

Referencia 552920-100ug

embalaje : 100ug

Marca : US Biological

Contact local distributor :


Teléfono : +1 850 650 7790


552920 FCGRT

Clone Type
Monoclonal
Host
mouse
Source
human
Isotype
IgG2a
Grade
Purified
Applications
E FC WB
Crossreactivity
Hu
Shipping Temp
Blue Ice
Storage Temp
-20°C

This gene encodes a receptor that binds the Fc region of monomeric immunoglobulin G. The encoded protein transfers immunoglobulin G antibodies from mother to fetus across the placenta. This protein also binds immunoglobulin G to protect the antibody from degradation. Alternative splicing results in multiple transcript variants.

Applications:
Suitable for use in ELISA, Flow Cytometry and Western Blot. Other applications not tested.

Recommended Dilution:
ELISA: 1:10,000
Flow Cytometry: 1:200-1:400
Western Blot: 1:500-1:2000
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Applications
Product Type: Mab|Isotype: IgG2a|Clone No: 2B3B11|Host: mouse|Source: human|Concentration: ~1mg/ml |Form: Supplied as a liquid in PBS, 0.05% sodium azide.|Purity: Purified|Immunogen: Purified recombinant protein fragment corresponding to aa: extra 24-297 from human FCGRT, expressed in E. coli.|Specificity: Recognizes human FCGRT.||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Immunogen
Purified recombinant protein fragment corresponding to aa: extra 24-297 from human FCGRT, expressed in E. coli.
Form
Supplied as a liquid in PBS, 0.05% sodium azide.
Purity
Purified
Specificity
Recognizes human FCGRT.
References
1. Genomics. 2017 Jul;109(3-4):251-257. |2. Exp Eye Res. 2017 Jan;154:39-46.